MS Drug Prices May Abate with Transparency After Eightfold Rise Since 1996
Amid outcries over exorbitant drug prices, the latest MS drug has been priced at $65,000 -- shy of the average of $78,000, but still several times higher than the $10,000 average in 1996. Drug manufacturers have hiked prices for other existing drugs even as new options have come on the market.
Expensive, complex drugs to treat Multiple Sclerosis are just getting more expensive, even as more options come onto the market.
This article is for premium subscribers!
To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!
If you are a premium subscriber that is not logged in, please login now.
